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Myeloid-derived suppressor cells (MDSCs) are innate immune cells characterize
their ability to suppress T-cell responses. Recently, we demonstrated that the hu
pathogenic fungi Candida albicans and Aspergillus fumigatus induced a distinct su
of neutrophilic MDSCs. To dissect Candida-mediated MDSC induction in more de
we studied the relative efficacy of different pathogenic non-albicans Candida spe
to induce and functionally modulate neutrophilic MDSCs, including C. glabrata
parapsilosis, C. dubliniensis, and C. krusei. Our data demonstrate that the exte
MDSC generation is largely dependent on the Candida species with MDSCs indu
by C. krusei and C. glabrata showing a higher suppressive activity compared to MD
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INTRODUCTION
Candida species cause one of the most prevalent fungal infections worldwide (Pfaller and Diekema,
2007; Brown et al., 2012). Among various Candida species, Candida albicans has been the model
organism for the most research studies focused on immunity against Candida infections (Papon
et al., 2013). However, the genus Candida consists of multiple species that show a considerable
variation in terms of their virulence and phenotype and recent studies showed that particularly
diseases caused by NAC species are on the rise (Merseguel et al., 2015).
While C. albicans is well characterized in terms of recognition through PRRs mainly CLRs
like Dectin-1, Dectin-2, mannose receptor (MR) and Mincle (Brown, 2010; Plato et al., 2015),
recognition of NAC species is less precisely defined. In contrast to C. albicans, phagocytosis
of C. parapsilosis by neutrophils was not impaired following Dectin-1 blockade in vitro
(Linden et al., 2010) and, dectin-1−/− bone marrow macrophages showed no defect in binding
to C. glabrata (Kuhn and Vyas, 2012). Interestingly, studies indicated that Dectin-2 also
played a more important role in C. glabrata infection than Dectin-1 (Ifrim et al., 2014).
Abbreviations: CFSE, Carboxyfluoresceinsuccinimidyl ester; DPI, Diphenyleneiodonium chloride; ELISA, Enzyme-linked
immunosorbent assay; FACS, Fluorescence-activated cell sorting; GM-CSF, Granulocyte-macrophage colony-stimulating
factor; G-MDSCs, Granulocytic myeloid-derived suppressor cells; IL-, Interleukin; MACS, Magnetic-activated cell sorting;
MDSCs, Myeloid-derived suppressor cells; M-MDSCs, Monocytic myeloid-derived suppressor cells; NAC, Non-albicans
Candida; PBMCs, Peripheral blood mononuclear cells; PRR, Pattern recognition receptor; ROS, Reactive oxygen species.
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There is also some evidence that T-cell responses are differentially
involved in immunity to NAC species. For example, C. albicans
and C. parapsilosis were shown to induce different T-cell
responses (Tóth et al., 2013), but underlying mechanisms by
which different Candida species exert a differential immune
response remained elusive.
Myeloid-derived suppressor cells are characterized by their
ability to suppress T-cell responses and have mainly been
studied in cancer (Bronte, 2009; Gabrilovich and Nagaraj, 2009).
However, expansion and involvement of MDSCs has also been
reported during various infectious disease conditions, such as
polymicrobial sepsis, tuberculosis, and Staphylococcus aureus
infections (Delano et al., 2007; Du Plessis et al., 2013; Tebartz
et al., 2014). Recently, we showed that C. albicans induces a
distinct subset of neutrophilic myeloid-derived suppressor cells
(G-MDSCs) which is mediated by a Dectin-1/CARD9 signaling
pathway, leading to dampening of T-cell and NK-cell responses
(Rieber et al., 2015).
To further broaden our understanding of how MDSCs play
a role in modulating the host immune response to Candida
infections, we studied the relative efficacy of different pathogenic
NAC species to induce neutrophilic MDSCs, including
C. glabrata, C. krusei, C. parapsilosis, and C. dubliniensis.
Our data demonstrate that the generation of MDSCs is
largely dependent on the Candida species and morphotype.
Further results also show, that Dectin-1 but not Dectin-2 has an
important role during NAC induced MDSC generation.
MATERIALS AND METHODS
Study Subjects
The study was conducted at the University Children’s Hospital
Tübingen (Germany). MDSCs were analyzed in primary cell
cultures from peripheral blood obtained from healthy subjects.
Informed consent was obtained from all subjects included in the
study and the local ethics committee approved all study methods.
At the time of blood sampling, all healthy subjects were without
any signs of infection, inflammation, or respiratory symptoms.
Candida Species and Culture Conditions
Candida albicans, C. krusei, C. glabrata, C. dubliniensis, and
C. parapsilosis strains were stored as frozen stocks in 35% glycerol
at −80◦C and routinely grown on Sabouraud (Sab) agar (1%
mycological peptone, 4% glucose, and 1.5% agar) and YPD
agar (1% yeast extract, 2% bacteriological peptone, 2% glucose,
and 1.5% agar) plates at 25◦C. One colony was inoculated and
shaken at 150 rpm at 30◦C in YPD broth (1% yeast extract,
2% bacteriological peptone, and 2% glucose) overnight. Cells
were harvested by centrifugation and washed twice in sterile
Dulbecco’s phosphate-buffered saline (PBS). Cells were counted
in a haemocytometer and density was adjusted to the desired
concentration in either PBS or RPMI 1640 medium. To generate
hyphae, live yeast forms of C. albicans were grown for 6 h at 37◦C
in RPMI 1640 medium (Gibco-BRL). Heat-inactivated Candida
cells were prepared by heat treatment of the cell suspension at
90◦C for 30 min.
In vitro MDSC Generation and Flow
Cytometry
Human MDSCs were generated in vitro as described previously
(Lechner et al., 2010; Rieber et al., 2015). In brief, isolated human
PBMCs were cultured in 24 well flat-bottom plates (Corning)
or 25 cm2 flasks (Greiner Bio-One) at 5 × 105 cells/ml in
RPMI 1640 supplemented with 10% heat-inactivated FCS (PAA
Laboratories), 2 mM glutamine (Sigma-Aldrich), 100 IU/ml
penicillin, and 100 mg/ml streptomycin (Biochrom; referred to
as “complete medium”) for 6 days, and GM-CSF (10 ng/ml,
Genzyme), heat-inactivated C. albicans, C. glabrata, C. krusei,
C. dubliniensis, and C. parapsilosis were added at a ratio of
1:5 (Fungi:PBMC) as indicated in figures. Dectin-1 antagonist
Laminarin obtained from Laminaria digitata (100 µg/ml, Sigma)
and Dectin-2 antagonist whole mannan particle preparation
isolated from Saccharomyces cerevisiae (100 µg/ml, Sigma) were
added in cell culture where indicated. For ROS inhibition assays,
PBMCs were incubated with NADPH oxidase inhibitor DPI
(DPI, 0.1 µM; Sigma-Aldrich) for 1 h prior to adding the
stimulants.
The number of MDSCs in % of all cells in medium only
cultures was set to 1-fold for every single experiment. The
MDSC induction due to the specific stimuli is presented as x-fold
compared to medium control. Medium and supplements were
refreshed on day 4 and supernatants were frozen for ELISA.
After 6 days, all cells were collected from PBMC cultures using
non-protease cell detachment solution Detachin (Genlantis).
G-MDSCs were characterized as CD33+CD11b+ CD14− cells as
described before (Rieber et al., 2013, 2015).
Cell Isolation and T-Cell Suppression
Assays
For functional assays, CD33+ MDSCs were isolated from
in vitro cultures using anti-CD33 magnetic microbeads and
autoMACS R©Pro Separator (Miltenyi Biotec) according to
manufacturer’s instructions. Morphology of the MDSCs was
analyzed by cytospin staining. For cytospin stainings 5 x 104
CD33+ cells were centrifuged in a Cytospin three centrifuge
(Shandon) at 800 rpm for 15 min followed by staining
with May-Grunwald-Giemsa method (Supplementary Figure
S1). T-cell suppression assays were performed as described
previously (Rieber et al., 2015). PBMCs were obtained from
healthy volunteers and stained with CFSE according to the
manufacturer’s protocol (Invitrogen). PBMCs were stimulated
with 100 U/ml IL-2 (R&D Systems) and 1 µg/ml OKT3 (Janssen
Cilag). Cell number was adjusted to 5 × 105 cells per ml and
a total of 60,000 PBMCs per well were seeded in RPMI1640
(Biochrom) medium, in a 96-well microtitre plate and different
numbers of MDSCs in RPMI1640 were added to get an MDSC:T-
cell ratio 1:2, 1;4, 1:8, 1:16, and 1:32. The cell culture was
supplemented with 10% heat-inactivated human serum, 2 mM
glutamine, 100 IU/ml penicillin, and 100 mg/ml streptomycin.
After 96 h of incubation in a humidified atmosphere at 37◦C
and 5% CO2, cells were harvested and supernatants were frozen
in −20◦C. CFSE-fluorescence intensity was analyzed by flow
cytometry to determine T-cell proliferation.
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Flow Cytometry
Antibodies against human CD4, CD8, and CD14 were purchased
from BD Pharmingen. Antibodies against CD11b and CD33
were purchased from Miltenyi Biotec. Flow cytometry was
performed using a FACSCalibur (BD). Results were expressed as
percent of positive cells and mean fluorescence intensity (MFI).
Calculations were performed with BD CellQuest Pro analysis
software and FlowJo.
Cytokine Analysis in Culture
Supernatants
IL-1β (R&D systems) and GM-CSF (Biolegend) ELISA Kits
were used to quantify cytokine protein levels in cell culture
supernatants. Released IFN-γ protein was quantified by using
the Human IFN-γ DuoSet (R&D Systems). All assays were
performed according to the manufacturer’s recommendations.
Statistical Analysis
Statistical analysis was performed in GraphPad Prism version 6.0
using a one-sample t-test. In all tests, differences were considered
significant at P < 0.05 (∗P < 0.05; ∗∗P < 0.01; ∗∗∗P < 0.001;
∗∗∗∗P < 0.0001).
RESULTS
Different Candida Species Induce
Functional G-MDSCs
First, we assessed the ability of NAC species to induce human
G-MDSCs and to control their function. G-MDSCs were
defined by their surface markers (CD11b+CD33+CD14−) and
by their characteristic to suppress T-cell responses. By comparing
Candida species, we found a differential pattern of MDSC
induction among all Candida species. While C. albicans (9.1-
fold) was the strongest inducer of G-MDSCs, C. krusei, and
C. glabrata (5.5- and 6.1-fold, respectively) also induced high
amounts of MDSCs, followed by C. parapsilosis (3.5-fold) and
C. dubliniensis (2.1-fold), which was least potent in comparison
to others (Figure 1A). G-MDSC induction by C. albicans was
observed for different fungal morphotypes and even occurred
using filter sterilized C. albicans yeast supernatants (Figure 1B).
M-MDSCs (CD11b+CD33+CD14+) were not induced during
these culture conditions. (Supplementary Figure S2).
MDSCs Induced by Non-albicans
Candida Species Are More Suppressive
than MDSCs Induced by C. albicans
The key function attributed to MDSCs is to suppress T-cell
responses. (Bronte et al., 2016). Therefore, we performed
functional assays to screen for T-cell suppression capability
of Candida-induced MDSCs. CFSE assays showed that NAS-
induced myeloid cells strongly suppressed both CD4+ and CD8+
T cell proliferation in a dose-dependent manner. Interestingly,
MDSCs induced by C. krusei and C. glabrata exhibited an even
higher suppressive activity than MDSCs induced by C. albicans,
an effect which was significant at MDSC:T cell ratios of 1:8 and
1:16. (Figures 2A,B). Apart from T-cell proliferation assays, we
also investigated the impact of fungi-derived MDSCs on IL-2
and OKT3-induced T cell cytokine production. These studies
demonstrated that MDSCs efficiently suppressed IFN-γ secretion
(Figure 2C).
Dectin-1, but not Dectin-2, Is Involved in
MDSC Induction by Non-albicans
Candida Species
In our previous work we showed that Dectin-1 plays a key role
in C. albicans-induced MDSC generation. Several studies also
reveal the role of Dectin-1 and also Dectin-2 (Saijo and Iwakura,
2011) in immune mechanisms against NAC species. We therefore
focussed on Dectin-1 and Dectin-2 as β-glucan and mannan
receptors, essentially involved in recognition of fungi. As shown
for C. albicans, blocking of Dectin-1 prior to co-culture with
fungal cells diminished the MDSC-inducing effect significantly
in C. glabrata. For C. krusei-induced MDSCs we observed a
similar, however, not significant effect. On the other hand,
blocking of Dectin-2 had no effect (Figure 3A) suggesting that
Dectin-2 is dispensable for Candida-mediated MDSC generation.
Since fundamental differences have been reported between host
recognition of C. albicans morphotypes (Lowman et al., 2014),
we next examined the impact of Dectin-1 blockage on MDSC
generation. In case of C. albicans yeast cells and hyphae, Dectin-
1 blockage significantly inhibited the MDSCs. Dectin-1 blockage
also led to a similar trend for filter sterilized C. albicans yeast cell
supernatant, however, it was not significant (Figure 3B).
Candida-Mediated MDSC Generation Is
Associated with GM-CSF, IL-1β, and ROS
Production
The cytokine GM-CSF has been involved in MDSC generation
(Gabrilovich and Nagaraj, 2009; Dolcetti et al., 2010) and
previous studies showed that GM-CSF is secreted upon
stimulation with fungal pathogens. (Li and Dongari-Bagtzoglou,
2009; Svobodová et al., 2012). Therefore we hypothesized
that GM-CSF might play a role in Candida-mediated MDSC
generation and analyzed the amount of GM-CSF in conditioned
medium obtained from PBMC-Candida co-culture. Our results
demonstrate that C. albicans stimulation leads to a high amount
of GM-CSF release in comparison to C. glabrata and C. krusei
(Figure 4A). In addition to GM-CSF, the inflammasome product
IL-1β has been previously involved in MDSC induction (Elkabets
et al., 2010; Lechner et al., 2011; Ballbach et al., 2016).
Hence, we quantified IL-1β protein in our assays and found
that C. albicans, C. glabrata, and C. krusei, all three major
pathogenic Candida species lead to high amounts of IL-1β
secretion upon PBMC stimulation (Figure 4B). These results
indicate that the two MDSC-related cytokines GM-CSF and
IL-1β seem to be associated with fungal MDSC induction.
ROS have been consistently involved in MDSC generation
and function (Gabrilovich and Nagaraj, 2009). To check the
role of ROS, MDSCs were generated in vitro by incubating
isolated PBMCs (5 × 105 cells/ml) with different Candida
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FIGURE 1 | In vitro MDSC generation by different Candida non-albicans species and C. albicans morphotypes. MDSCs were generated by incubating
freshly isolated PBMCs (5 × 105/ml) from healthy donors with medium only (negative control) or indicated stimulants. (A) PBMCs were cultured with heat killed yeast
cells of C. albicans, C. glabrata, C. krusei, C. parapsilosis, and C. dubliniensis (1 × 105/ml) for 6 days (n = 11–20) or (B) with heat killed C. albicans yeast cells
(1 × 105/ml), filter sterilized C. albicans yeast supernatant (5% SNT), or C. albicans hyphae (1 × 105/ml) for 6 days (n = 8–13). Granulocytic MDSCs
(CD11b+CD33+CD14−) were quantified by using Flow Cytometry. The number of MDSCs in % of all cells in medium only cultures was set to 1-fold for every single
experiment. The MDSC induction due to specific stimuli is presented as x-fold compared to medium control (mean ± SEM) and differences compared to controls
were analyzed by a one-sample t-test. Significant differences between control and G-MDSCs induction by stimulants are indicated by an asterisk (∗P < 0.05;
∗∗P < 0.01; ∗∗∗P < 0.001; ∗∗∗∗P < 0.0001).
FIGURE 2 | Candida-induced MDSCs suppress T cell responses. MDSCs generated by Candida species are able to suppress T-cell proliferation and function
in a dose dependent manner. The suppressive effects of CD33+-MACS-isolated MDSCs on CD4+ (green) and CD8+ (lilac) were assessed by T-cell proliferation
(CFSE polyclonal proliferation) assay. MDSCs were generated by incubating PBMCs (5 × 105/ml) from healthy donors with heat killed yeast cells of various Candida
species (1 × 105/ml) or C. albicans yeasts for 6 days. (A) Representative CFSE stainings, showing the effect of in vitro C. albicans, C. krusei, and C. glabrata
induced MDSCs on CD4+ and CD8+ T-cell proliferation. Different MDSC to T cell ratios were assessed by using a wide range of MDSC:Target ratio (1:2, 1:4, 1:6,
1:8, and 1:16). (B) The bar graphs represent the proliferation index compared to control conditions. Even at a higher MDSC:target ratio of 1:16, MDSCs induced by
C. krusei, and C. glabrata show higher suppressive activity in comparison to C. albicans. Data is shown as mean ± SEM (n = 4) ∗∗P < 0.01. (C) IFNγ secretion of T
cells is decreased by MDSCs. IFNγ secretion in the supernatant was measured on day 4 of MDSC/T cell co-culture experiments by ELISA. The concentration is
given in pg/ml (n = 3).
stimulants (1 × 105 cells/ml) and pretreatment for 1 h with
the NADPH oxidase inhibitor DPI (0.1 µM) where indicated.
These experiments showed that ROS contributed substantially to
fungi-mediated MDSC induction in vitro (Figure 4C).
DISCUSSION
Previous studies from our group demonstrated that pathogenic
fungi A. fumigatus and C. albicans induce MDSCs, which
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FIGURE 3 | Dectin-1 is involved in Candida-mediated MDSC induction in vitro. MDSCs were generated in vitro by incubating isolated PBMCs
(5 × 105 cells/ml) with stimulants and inhibitors. (A) with heat killed yeast cells of C. albicans, C. krusei, and C. glabrata (all 1 × 105/ml), (n = 8–11) or (B) with heat
killed C. albicans yeast cells (1 × 105/ml), filter sterilized C. albicans yeast cell supernatant (5% SNT) or C. albicans hyphae for 6 days (n = 8–13). Where indicated,
prior to stimulation, PBMCs were pretreated for 60 min with Dectin-1 inhibitor Laminarin (100 µg/ml) or Mannan (100 µg/ml) from Saccharomyces cerevisea to
mimic Dectin-2 binding without receptor activating capacity. (∗P < 0.05, Bars represent SEM).
FIGURE 4 | Candida-mediated MDSC generation involves GM-CSF, IL-1β, and ROS. GM-CSF, IL-1β, and ROS are involved in Candida-mediated MDSC
generation. Freshly isolated PBMCs (5 × 105 cells/ml) were cultured in medium only, or with heat killed yeast cells of C. albicans (1 × 105/ml), C. krusei
(1 × 105 cells/ml), and C. glabrata (1 × 105 cells/ml) for 4 days. For quantification of cytokines, co-culture supernatants were collected on day 4. (A) GM-CSF
(n = 8) and (B) IL-1β (n = 6) levels were quantified by ELISA. (C) MDSCs were generated in vitro by incubating isolated PBMCs (5 × 105 cells/ml) with with heat
killed yeast cells of C. albicans (1 × 105/ml), C. krusei (1 × 105 cells/ml), and C. glabrata (1 × 105 cells/ml) for 6 days. Prior to stimulation, PBMCs were pretreated
for 60 min where indicated with the NADPH oxidase inhibitor DPI (0.1 µM; n = 6) (∗P < 0.05, Bars represent SEM).
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suppress T cell responses (Rieber et al., 2015). In this study, we
compared the capacity of C. albicans, C. glabrata, C. krusei, and
C. parapsilosis to induce G-MDSCs and the relative strength of
Candida-induced G-MDSCs to suppress T-cell proliferation and
cytokine production.
Candida species are found as commensal organisms at
mucosal surfaces in the human body. Since C. albicans is the
most prominent fungus isolated from clinical samples, research
related to anti-fungal immune response is largely centered on
it. However, recent clinical studies have reported a rise in the
NAC species isolated from clinical samples of fungal infections.
NAC species associated with disease mainly include C. glabrata,
C. krusei, C. dubliniensis, and C. parapsilosis (Butler et al.,
2009). Here we extend our previous findings by showing that
the strength of Candida-mediated MDSC induction substantially
depends on the Candida species. While C. albicans was the
strongest inducer of MDSCs, C. dubliniensis showed the lowest
capacity. Importantly, our studies further show that not only
the extent, but also the functionality of MDSCs is regulated by
distinct Candida species. Collectively, these studies add to our
understanding of how different Candida species differentially
modulate host immunity.
Candida species consist of a diverse range of virulence factors
and morphotypes. Although limited in number, studies using
in vitro methods and in vivo infection strategies demonstrate that
host innate immune responses to Candida challenge including
activation and function of neutrophils (Dementhon et al.,
2012; Svobodová et al., 2012; Duggan et al., 2015), dendritic
cells (Bourgeois et al., 2011), and macrophages (Seider et al.,
2011) differ depending on the Candida species. In addition to
different species, we also used C. albicans yeast and hyphal
forms and filter sterilized supernatant from yeast cultures to
study the impact of different fungal morphotypes and soluble
products during fungi-mediated MDSC generation. C. albicans
yeast to hyphae morphogenesis has been attributed as a crucial
virulence factor during fungal pathogenesis. Various studies
demonstrate that immune cell recognition and subsequent
immune response toward different morphotypes of C. albicans
differs (Lewis et al., 2012; Lowman et al., 2014) due to differential
exposure of cell wall components, e.g., β-glucans (Wheeler
et al., 2008; Gow et al., 2011). However, in our studies, we
did not find a difference in MDSC induction after stimulation
with C. albicans yeast and hyphae (Rieber et al., 2015) or
supernatants. Further studies involving various morphotypes of
different NAC species and secreted fungal virulence factors will
help to dissect the mechanism underlying Candida-mediated
MDSC generation and function. T cells are pivotal immune cells
during C. albicans infection and patients with decreased CD4+
T cells were found to be highly susceptible to mucocutaneous
and invasive Candidiasis (Fidel, 2011; Lionakis and Netea, 2013).
Interestingly, C. glabrata and C. krusei-generated MDSCs were
more suppressive on T cell proliferation than C. albicans-
generated MDSCs and this phenomenon was recapitulated in the
suppression of IFNγ release. There is some evidence suggesting
differential T-cell responses depending on the Candida species.
C. albicans and C. parapsilosis were found to induce different
T-cell responses and cytokines. Human PBMCs stimulated with
heat killed C. parapsilosis yeast cells showed higher production
of IL-10 but lower amounts of IL-1β, IFNγ, IL-17, and IL-
22, when compared to cells stimulated with C. albicans (Tóth
et al., 2013). Another study reported distinct T-cell generation
in response to C. albicans and NAC species and T cells
generated after stimulation with C. albicans displayed cross-
reactivity only with C. tropicalis but not C. glabrata (Tramsen
et al., 2007). Our findings now also hint toward a species-
dependent innate immune response against different Candida
species. The induction of MDSCs might contribute to a fine-
tuned balance between pro-inflammatory effector and counter-
regulatory immune mechanisms, which has been demonstrated
to be crucial for an effective anti-fungal immune response
(Zelante et al., 2011, 2012; Rieber et al., 2015).
Candida albicans is recognized by different classes of PRRs
among which, the CLRs including Dectin-1and Dectin-2 are the
most important ones described so far. In our previous work, we
showed that dectin-1 mediated signaling was prominent in fungi-
induced MDSC generation. While Dectin-1 has been shown to be
the key PRR for C. albicans (Taylor et al., 2007; Marakalala et al.,
2013), Dectin-2 has emerged as a leading PRR to recognize both
C. albicans and C. glabrata (Saijo et al., 2010; Ifrim et al., 2014).
Therefore we focussed on these two PRRs to clarify their role
in Candida-mediated MDSC generation. In consistence with our
previous findings for C. albicans (Rieber et al., 2015), we found
that blockage of Dectin-1 but not Dectin-2 led to diminished
MDSC generation by C. albicans, C. glabrata, and C. krusei. Our
results demonstrate that Candida-mediated MDSC induction is
dependent on the type of Candida species, which is in line
with the notion that anti-fungal immune responses are species-
and strain-specific and vary in terms of recognition by the host
immune system (Netea et al., 2010; Marakalala et al., 2013).
Future studies will be essential to expand the understanding
how differential adaptation of Candida strains plays a role in
MDSC generation. Different morphotypes of C. albicans induce
an altered immune response. It has been reported that C. albicans
yeast cells and hyphae are differentially recognized by Dectin-
1 and Dectin-2 during host-pathogen-interaction (Saijo et al.,
2010; Saijo and Iwakura, 2011). We observed a similar MDSC
induction independent of the C. albicans morphotype. Dectin-
1 blockage significantly inhibited the MDSC generation by
C. albicans yeast cells and hyphae, and led to a similar trend
for C. albicans supernatant. This hints toward the presence
of a soluble Dectin-1 ligand in C. albicans supernatant that
contributes to MDSC generation. Interestingly, while yeast
mannan particles have been described to impact not only Dectin-
2, but also other PRRs like MR, DC-SIGN, and Mincle (Netea
et al., 2015), we did not observe any effect of mannan treatment
on Candida-mediated MDSC generation in our studies.
To elucidate the mechanism of Candida-mediated MDSC
induction, we further focused on two key cytokines, GM-CSF
and IL-1β, both reported to play an important role in MDSC
generation and homeostasis (Elkabets et al., 2010; Lechner et al.,
2011; Gabrilovich et al., 2012; Bayne et al., 2016), as well as during
fungal pathogenesis (Svobodová et al., 2012; Netea et al., 2015).
Stimulation of PBMCs with C. albicans and NAC species led
to release of GM-CSF and IL-1β. C. albicans-mediated release
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of GM-CSF was significantly higher than that of C. glabrata,
possibly explaining the stronger induction of MDSCs upon
C. albicans stimulation. All three species C. albicans, C. glabrata,
and C. krusei released similar amounts of IL-1β upon PBMC
stimulation. Since Dectin-1 was found to be the key receptor
for Candida-mediated MDSC generation, and previous studies
demonstrated that ROS act downstream of Dectin-1 (Branzk
et al., 2014), and ROS have been shown to be involved in MDSC
homeostasis (Corzo et al., 2010; Gabrilovich et al., 2012), we
further examined the role of ROS for Candida-mediated MDSC
induction. These studies demonstrated that ROS contributed
substantially to NAC-mediated MDSC induction in vitro.
CONCLUSION
Our results demonstrate that Candida-mediated MDSC
induction is differentially regulated at the species level and
differentially affects effector T-cell responses. In our previous
study using a systemic infection mouse model for C. albicans, we
showed that adaptive transfer with MDSCs leads to a protective
effect against invasive Candidiasis. While the classical MDSC
inducing factor GM-CSF has already been proposed as one of the
leading candidates for anti-fungal adjunctive therapy (Vazquez
et al., 1998; van de Veerdonk et al., 2012), in vivo generation of
MDSCs or ex vivo expansion and adoptive transfer might become
an interesting approach for future therapeutic strategies against
infections caused by Candida species.
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